Novartis Bioventures Ltd 13D and 13G filings for Annexon, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:30 pm Sale |
2021-12-31 | 13G | Annexon, Inc. ANNX |
Novartis Bioventures Ltd | 910,747 2.370% |
-1,196,497 (-56.78%) |
Filing |
| 2021-01-29 09:07 am Purchase |
2020-12-31 | 13G | Annexon, Inc. ANNX |
Novartis Bioventures Ltd | 2,107,244 5.520% |
2,107,244 (New Position) |
Filing |